DR_SEQAN:: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes

被引:11
|
作者
Garriga, C [1 ]
Menéndez-Arias, L [1 ]
机构
[1] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
关键词
D O I
10.1186/1471-2334-6-44
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Genotypic assays based on DNA sequencing of part or the whole reverse transcriptase (RT)- and protease (PR)-coding regions of the human immunodeficiency virus type 1 (HIV-1) genome have become part of the routine clinical management of HIV-infected individuals. However, the results are difficult to interpret due to complex interactions between mutations found in viral genes. Results: DR_SEQAN is a tool to analyze RT and PR sequences. The program output includes a list containing all of the amino acid changes found in the query sequence in comparison with the sequence of a wild-type HIV-1 strain. Translation of codons containing nucleotide mixtures can result in potential ambiguities or heterogeneities in the amino acid sequence. The program identifies all possible combinations of 2 or 3 amino acids that derive from translation of triplets containing nucleotide mixtures. In addition, when ambiguities affect codons relevant for drug resistance, DR_SEQAN allows the user to select the appropriate mutation to be considered by the program's drug resistance interpretation algorithm. Resistance is predicted using a rule-based algorithm, whose efficiency and accuracy has been tested with a large set of drug susceptibility data. Drug resistance predictions given by DR_SEQAN were consistent with phenotypic data and coherent with predictions provided by other publicly available algorithms. In addition, the program output provides two tables showing published drug susceptibility data and references for mutations and combinations of mutations found in the analyzed sequence. These data are retrieved from an integrated relational database, implemented in Microsoft Access, which includes two sets of non-redundant core tables (one for combinations of mutations in the PR and the other for combinations in the RT). Conclusion: DR_SEQAN is an easy to use off-line application that provides expert advice on HIV genotypic resistance interpretation. It is coded in Visual Basic for use in PC/Windows-based platforms. The program is freely available under the General Public License. The program (including the integrated database), documentation and a sample sequence can be downloaded from http://www2.cbm.uam.es:8080/Imenendez/DR_SEQAN.zip
引用
收藏
页数:8
相关论文
共 50 条
  • [1] DR_SEQAN: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes
    César Garriga
    Luis Menéndez-Arias
    BMC Infectious Diseases, 6
  • [2] Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update
    Shafer, Robert W.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S843 - S846
  • [3] Genotypic testing for human immunodeficiency virus type 1 drug resistance
    Shafer, RW
    CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (02) : 247 - +
  • [4] Genotypic predictors of human immunodeficiency virus type 1 drug resistance
    Rhee, Soo-Yon
    Taylor, Jonathan
    Wadhera, Gauhar
    Ben-Hur, Asa
    Brutlag, Douglas L.
    Shafer, Robert W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (46) : 17355 - 17360
  • [5] Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance
    Lori, F
    Malykh, AG
    Foli, A
    Maserati, R
    DeAntoni, A
    Minoli, L
    Padrini, DA
    DegliAntoni, A
    Barchi, E
    Jessen, H
    Wainberg, MA
    Gallo, RC
    Lisziewicz, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (16) : 1403 - 1409
  • [6] Human immunodeficiency virus type 1: Drug resistance in treated and untreated Brazilian children
    Simonetti, SRR
    Schatzmayr, HG
    Simonetti, PP
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2003, 98 (06): : 831 - 837
  • [7] A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene
    Van Laethem, K
    Schrooten, Y
    Lemey, P
    Van Wijngaerden, E
    De Wit, S
    Van Ranst, M
    Vandamme, AM
    JOURNAL OF VIROLOGICAL METHODS, 2005, 123 (01) : 25 - 34
  • [8] Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods
    Erali, M
    Page, S
    Reimer, LG
    Hillyard, DR
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) : 2157 - 2165
  • [9] Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing
    McNulty, Amanda
    Jennings, Cheryl
    Bennett, Diane
    Fitzgibbon, Joseph
    Bremer, James W.
    Ussery, Michael
    Kalish, Marcia L.
    Heneine, Walid
    Garcia-Lerma, J. Gerardo
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) : 517 - 521
  • [10] Hydrophobic sliding: A possible mechanism for drug resistance in human immunodeficiency virus type 1 protease
    Foulkes-Murzycki, Jennifer E.
    Scott, Walter Robert Peter
    Schiffer, Celia A.
    STRUCTURE, 2007, 15 (02) : 225 - 233